1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Ascites in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P; Arroyo, V; Bosch-Marcé, M; Clària, J; Graziotto, A; Jiménez, W; Leivas, A; Rivera, F; Rodés, J | 1 |
1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Ascites
| Article | Year |
|---|---|
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ascites; Benzeneacetamides; Blood Pressure; Body Water; Diuresis; Heart Rate; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Vasopressins | 1995 |